Decision Resources, Inc., Sep 2011
and ulcerative colitis), and dermatology (psoriasis and systemic lupus erythematosus).
Primary research: Insight from a physiciansurvey of 78 specialists (27 gastroenterologists, 26 rheumatologists, and 25
Frost & Sullivan, May 2010, Pages: 47
This study encompasses feedback provided by U.S. physicians who treat diabetes on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight
Datamonitor, Dec 2010, Pages: 198
market
Related reports
OVERVIEW
Catalyst
Summary
1. INTRODUCTION AND SCOPE
Coverage of the Stakeholder InsightSurvey
Country treatment trees
Epidemiology
Patient segmentation
Datamonitor, Dec 2010, Pages: 221
, Keppra.
Executive Summary
Scope of the analysis
Datamonitor insight into the epilepsy market
Related reports
OVERVIEW
Catalyst
Summary
1. INTRODUCTION AND SCOPE
Coverage
CEOutcomes LLC, Nov 2011, Pages: 41
was conducted to ascertain the current attitudes and practice of physicians regarding opioid therapies, a survey was designed and distributed to primary care physicians (PCPs) through an online link in October
Decision Resources, Inc., Sep 2008, Pages: 21
into a product’s adoption in the market?
Scope
- Specialist opinions: obstetricians/gynecologists were surveyed to determine their opinions on current and emerging contraceptives.
- Overview of oral
Eularis, June 2011, Pages: 84
: Doctor Perspective - UK Doctors attitudes and acceptance (surveyresults) - Background and objective - Overview of findings - Detailing findings - Unaided responses - Research Recommendations
Datamonitor, Nov 2010, Pages: 276
A
Abbreviations
Physician research methodology
Physician sample breakdown
Contributing experts
APPENDIX B
The survey questionnaire
Datamonitor consulting
Disclaimer
Stakeholder Insight: Breast
Datamonitor, March 2009, Pages: 137
Factors influencing a prescribing decision can diverge from clinical facts. In the highly competitive autoimmune area, misconceptions and physician habits can result in loss of sales. Targeted
Datamonitor, Dec 2010, Pages: 182
into COPD in emerging markets based on a survey of 300 physicians in Brazil, India, China, and the US
-Robust and comparable epidemiology estimates of the current COPD patient population in Brazil, India
Datamonitor, Dec 2009, Pages: 247
manufacturers
Scope
- Snapshot of the cancer pain market based on a survey of 180 physicians, supplemented with interviews with seven key opinion leaders.
- Overview of cancer pain prevalence, including three
BioInformatics, LLC, May 2009, Pages: 175
of performance and allows for side-by-side comparisons of the market's leading companies. SECTION 1. Analysis and Interpretation of
SurveyResults
- Executive Overview
- Study Objectives
- Antibody Sources
BioInformatics, LLC, Nov 2008, Pages: 154
, as well as grapple with a changing business model resulting from societal and economic forces. Some scientists, especially pioneers of the Open Access moment, have prophesied the end of traditional
GBI Research, Oct 2010, Pages: 120
informed business decisions from the insightful and in-depth analysis of the sales force effectiveness and the factors shaping it. “Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increases
BioInformatics, LLC, Feb 2008, Pages: 135
’ questionnaire
- Vendors’ questionnaire
Appendices
- Insights and Perspectives Conference & Exhibit Strategies in the Life Sciences: What’s Working Now is based on responses to a 37-question online survey
Datamonitor, Nov 2011, Pages: 77
the strongest competition lies.
- Gain insight into COPD market dynamics, and see where untapped market potential remains.
- Understand how currently marketed products are vulnerable to competition in the COPD
